Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000886692 | SCV001788115 | likely benign | not provided | 2018-10-12 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001799005 | SCV002043193 | likely benign | Cardiomyopathy | 2021-01-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002065508 | SCV002393651 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-06-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307665 | SCV004001610 | likely benign | Cardiovascular phenotype | 2023-05-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000886692 | SCV005211366 | likely benign | not provided | criteria provided, single submitter | not provided |